These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 20881389)

  • 1. Impact of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on the long-term outcome after pulmonary vein isolation for paroxysmal atrial fibrillation.
    Klemm HU; Heitzer T; Ruprecht U; Meinertz T; Ventura R
    Cardiology; 2010; 117(1):14-20. PubMed ID: 20881389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reducing the risk of recurrences after pulmonary vein isolation: what is the role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers?
    Steinberg JS; Garikipati NV
    Cardiology; 2010; 117(1):11-3. PubMed ID: 20881388
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapy with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and statins: no effect on ablation outcome after ablation of atrial fibrillation.
    Richter B; Derntl M; Marx M; Lercher P; Gössinger HD
    Am Heart J; 2007 Jan; 153(1):113-9. PubMed ID: 17174648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy with renin-angiotensin system blockers after pulmonary vein isolation in patients with atrial fibrillation: who is a responder?
    Berkowitsch A; Neumann T; Kuniss M; Janin S; Wojcik M; Zaltsberg S; Mitrovic V; Pitschner HF
    Pacing Clin Electrophysiol; 2010 Sep; 33(9):1101-11. PubMed ID: 20487340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of statins and renin-angiotensin system blockers on atrial fibrillation recurrence following antral pulmonary vein isolation.
    Al Chekakie MO; Akar JG; Wang F; Al Muradi H; Wu J; Santucci P; Varma N; Wilber DJ
    J Cardiovasc Electrophysiol; 2007 Sep; 18(9):942-6. PubMed ID: 17593228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renin-angiotensin system blocker use may be associated with suppression of atrial fibrillation recurrence after pulmonary vein isolation.
    Ishikawa K; Yamada T; Yoshida Y; Takigawa M; Aoyama Y; Inoue N; Tatematsu Y; Nanasato M; Kato K; Tsuboi N; Hirayama H
    Pacing Clin Electrophysiol; 2011 Mar; 34(3):296-303. PubMed ID: 21091729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of statins and renin-angiotensin-aldosterone system blockers on pulmonary vein antrum isolation outcomes in post-menopausal females.
    Patel D; Mohanty P; Di Biase L; Wang Y; Shaheen MH; Sanchez JE; Horton RP; Gallinghouse GJ; Zagrodzky JD; Bailey SM; Burkhardt JD; Lewis WR; Diaz A; Beheiry S; Hongo R; Al-Ahmad A; Wang P; Schweikert R; Natale A
    Europace; 2010 Mar; 12(3):322-30. PubMed ID: 20064822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary vein antral isolation for paroxysmal atrial fibrillation: results from long-term follow-up.
    Medi C; Sparks PB; Morton JB; Kistler PM; Halloran K; Rosso R; Vohra JK; Kumar S; Kalman JM
    J Cardiovasc Electrophysiol; 2011 Feb; 22(2):137-41. PubMed ID: 20812937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of angiotensin-converting enzyme-inhibitors and angiotensin receptor blockers on long-term outcome of catheter ablation for atrial fibrillation.
    Tayebjee MH; Creta A; Moder S; Hunter RJ; Earley MJ; Dhinoja MB; Schilling RJ
    Europace; 2010 Nov; 12(11):1537-42. PubMed ID: 20682557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epicardial off-pump pulmonary vein isolation and vagal denervation improve long-term outcome and quality of life in patients with atrial fibrillation.
    Bagge L; Blomström P; Nilsson L; Einarsson GM; Jidéus L; Blomström-Lundqvist C
    J Thorac Cardiovasc Surg; 2009 May; 137(5):1265-71. PubMed ID: 19380002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of renin-angiotensin system: a supplementary treatment for circumferential pulmonary vein isolation in treating persistent atrial fibrillation.
    Dai SM; Zhang S; Chu JM; Guo YH; Chen KP; Yao Sy
    Med Hypotheses; 2007; 69(4):767-72. PubMed ID: 17475415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissociated pulmonary vein potentials following antral pulmonary vein isolation for atrial fibrillation: impact on long-term outcome.
    Lee G; Kalman JM; Vohra JK; Teh A; Medi C; Ling LH; Kistler PM
    Heart; 2011 Apr; 97(7):579-84. PubMed ID: 21296779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ARBs, ACE-Is, or statins after catheter ablation of atrial fibrillation?
    Deneke T
    J Cardiovasc Electrophysiol; 2007 Sep; 18(9):947-9. PubMed ID: 17666057
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term clinical results of 2 different ablation strategies in patients with paroxysmal and persistent atrial fibrillation.
    Gaita F; Caponi D; Scaglione M; Montefusco A; Corleto A; Di Monte F; Coin D; Di Donna P; Giustetto C
    Circ Arrhythm Electrophysiol; 2008 Oct; 1(4):269-75. PubMed ID: 19808418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of age on the outcome of pulmonary vein isolation for atrial fibrillation using circular mapping technique and cooled-tip ablation catheter:
    Bhargava M; Marrouche NF; Martin DO; Schweikert RA; Saliba W; Saad EB; Bash D; Williams-Andrews M; Rossillo A; Erciyes D; Khaykin Y; Burkhardt JD; Joseph G; Tchou PJ; Natale A
    J Cardiovasc Electrophysiol; 2004 Jan; 15(1):8-13. PubMed ID: 15028066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recovered pulmonary vein conduction as a dominant factor for recurrent atrial tachyarrhythmias after complete circular isolation of the pulmonary veins: lessons from double Lasso technique.
    Ouyang F; Antz M; Ernst S; Hachiya H; Mavrakis H; Deger FT; Schaumann A; Chun J; Falk P; Hennig D; Liu X; Bänsch D; Kuck KH
    Circulation; 2005 Jan; 111(2):127-35. PubMed ID: 15623542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left atrial volume at MRI is the main determinant of outcome after pulmonary vein isolation plus linear lesion ablation for paroxysmal-persistent atrial fibrillation.
    Montefusco A; Biasco L; Blandino A; Cristoforetti Y; Scaglione M; Caponi D; Di Donna P; Boffano C; Cesarani F; Coin D; Perversi J; Gaita F
    J Cardiovasc Med (Hagerstown); 2010 Aug; 11(8):593-8. PubMed ID: 20216228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term clinical outcome of extensive pulmonary vein isolation-based catheter ablation therapy in patients with paroxysmal and persistent atrial fibrillation.
    Miyazaki S; Kuwahara T; Kobori A; Takahashi Y; Takei A; Sato A; Isobe M; Takahashi A
    Heart; 2011 Apr; 97(8):668-73. PubMed ID: 20720249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers decrease the incidence of atrial fibrillation: a meta-analysis.
    Huang G; Xu JB; Liu JX; He Y; Nie XL; Li Q; Hu YM; Zhao SQ; Wang M; Zhang WY; Liu XR; Wu T; Arkin A; Zhang TJ
    Eur J Clin Invest; 2011 Jul; 41(7):719-33. PubMed ID: 21250983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upstream therapies after pulmonary vein ablation: five negative studies--what's next?
    Savelieva I; Camm AJ
    Europace; 2010 Nov; 12(11):1509-13. PubMed ID: 20974763
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.